Antidote Technologies and XpertPatient partner to empower newly-diagnosed cancer patients to take part in clinical research

We’re excited to share that today, we announced a partnership with XpertPatient, an award-winning educational website that provides support to newly-diagnosed cancer patients. We are providing the XpertPatient community with access to Antidote Match™, our patient-friendly clinical trial search that currently powers clinical trial matching for 300+ patient organizations.

Continue reading

7 clinical trial patient recruitment and retention tips

Clinical trial patient recruitment is a major challenge in the industry — 85% of trials fail to recruit enough patients, 80% are delayed due to recruitment problems, and dropout rates soar. Both at the recruitment and retention stages, taking a patient-centric approach to clinical trial design is a must in order to set your trial up for success.

Continue reading

Talk of the Towne episode 06: XpertPatient

Talk of the Towne is a podcast from Antidote focused on that special place where science and patients converge. It’s hosted by Richard Towne, PharmD, Antidote’s Senior Clinical Informatics Manager. Each episode, Talk of the Towne features a new guest from an Antidote partner organization, and takes an in-depth look at particular therapeutic areas, zeroing in on the story that our data is telling ...

Continue reading

World Cancer Day cancer research roundup

The statistics about the prevalence of cancer can be disheartening. Over 10 million people die each year from cancer, making it one of the leading causes of death — and unfortunately, researchers have yet to find a cure for many cancers.

Continue reading

How we randomized 75 patients into a knee osteoarthritis clinical trial [case study]

Osteoarthritis (OA) is the most common type of arthritis that impacts the knee joint. It is a result of the knee cartilage progressively wearing away, which can lead to difficulty moving, stiffness, and weakness, all of which worsen with time. Knee OA makes up 80% of diagnosed osteoarthritis cases, impacting 19% of adults over the age of 45.

Continue reading

Antidote is attending SCOPE 2023

We’re always excited to get a chance to connect with people in the clinical trial industry, and this year, we’re thrilled to share that we’ll be attending SCOPE 2023 from February 6 to 9 in Orlando, Florida.

Continue reading

What causes osteoporosis?

Osteoporosis, translated directly to “porous bone,” is a condition that impacts approximately 10 million Americans. The human body is constantly producing bone cells, but they are constantly being lost as well — and when the cells are being dissolved faster than they are being produced, weakness can result. Below, we’ll be taking a closer look at what osteoporosis is, what causes it, and how ...

Continue reading

5 ways to increase diversity in your clinical trial

Increasing diversity, equity, and inclusion (DEI) in clinical trials is a topic that has received a lot of attention in recent years, especially on the heels of the most recent guidance from the Food and Drug Administration — but it is still an area ripe for improvement.

Continue reading

25+ useful clinical trial recruitment statistics for better results

Oftentimes, clinical trial enrollment statistics paint a grim picture of the medical research landscape. A frequently-cited statistic is that approximately 80% of clinical trials are delayed or closed because of problems with recruitment, and there are other troubling statistics such as:

Continue reading

National Glaucoma Awareness Month: A Q&A with BrightFocus

National Glaucoma Awareness Month is a campaign aimed at increasing awareness around glaucoma, a leading cause of vision loss and blindness with no early warning signs.

Continue reading

Get our latest posts in your inbox